vs
Side-by-side financial comparison of Confluent, Inc. (CFLT) and Ralliant Corp (RAL). Click either name above to swap in a different company.
Ralliant Corp is the larger business by last-quarter revenue ($554.6M vs $314.8M, roughly 1.8× Confluent, Inc.). Confluent, Inc. runs the higher net margin — -25.2% vs -220.4%, a 195.3% gap on every dollar of revenue. On growth, Confluent, Inc. posted the faster year-over-year revenue change (20.5% vs 1.2%).
Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.
CFLT vs RAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $314.8M | $554.6M |
| Net Profit | $-79.2M | $-1.2B |
| Gross Margin | 74.7% | 50.5% |
| Operating Margin | -31.5% | — |
| Net Margin | -25.2% | -220.4% |
| Revenue YoY | 20.5% | 1.2% |
| Net Profit YoY | 10.0% | — |
| EPS (diluted) | $-0.23 | $-12.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $554.6M | ||
| Q4 25 | $314.8M | — | ||
| Q3 25 | $298.5M | $529.1M | ||
| Q2 25 | $282.3M | $503.3M | ||
| Q1 25 | $271.1M | — | ||
| Q4 24 | $261.2M | — | ||
| Q3 24 | $250.2M | $531.7M | ||
| Q2 24 | $235.0M | $533.7M |
| Q1 26 | — | $-1.2B | ||
| Q4 25 | $-79.2M | — | ||
| Q3 25 | $-66.5M | $39.9M | ||
| Q2 25 | $-82.0M | $47.6M | ||
| Q1 25 | $-67.6M | — | ||
| Q4 24 | $-88.1M | — | ||
| Q3 24 | $-74.1M | $90.9M | ||
| Q2 24 | $-89.9M | $64.8M |
| Q1 26 | — | 50.5% | ||
| Q4 25 | 74.7% | — | ||
| Q3 25 | 74.2% | 50.8% | ||
| Q2 25 | 73.7% | 49.3% | ||
| Q1 25 | 74.5% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 74.5% | 52.6% | ||
| Q2 24 | 72.3% | 51.5% |
| Q1 26 | — | — | ||
| Q4 25 | -31.5% | — | ||
| Q3 25 | -27.9% | 9.8% | ||
| Q2 25 | -34.2% | 11.7% | ||
| Q1 25 | -37.3% | — | ||
| Q4 24 | -40.5% | — | ||
| Q3 24 | -37.4% | 20.9% | ||
| Q2 24 | -46.1% | 19.7% |
| Q1 26 | — | -220.4% | ||
| Q4 25 | -25.2% | — | ||
| Q3 25 | -22.3% | 7.5% | ||
| Q2 25 | -29.0% | 9.5% | ||
| Q1 25 | -24.9% | — | ||
| Q4 24 | -33.7% | — | ||
| Q3 24 | -29.6% | 17.1% | ||
| Q2 24 | -38.3% | 12.1% |
| Q1 26 | — | $-12.10 | ||
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $-0.19 | $0.35 | ||
| Q2 25 | $-0.24 | $0.42 | ||
| Q1 25 | $-0.20 | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.23 | $0.81 | ||
| Q2 24 | $-0.28 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $347.2M | $318.8M |
| Total DebtLower is stronger | $1.1B | $1.1B |
| Stockholders' EquityBook value | $1.2B | $1.6B |
| Total Assets | $3.0B | $3.8B |
| Debt / EquityLower = less leverage | 0.94× | 0.70× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $318.8M | ||
| Q4 25 | $347.2M | — | ||
| Q3 25 | $298.5M | $264.2M | ||
| Q2 25 | $295.6M | $198.6M | ||
| Q1 25 | $278.6M | — | ||
| Q4 24 | $386.0M | — | ||
| Q3 24 | $322.6M | — | ||
| Q2 24 | $311.3M | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.1B | $3.0B | ||
| Q2 25 | $1.1B | $3.0B | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $961.2M | — | ||
| Q3 24 | $934.3M | $4.0B | ||
| Q2 24 | $873.9M | $4.0B |
| Q1 26 | — | $3.8B | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $2.9B | $5.3B | ||
| Q2 25 | $2.8B | $5.2B | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | — | 0.70× | ||
| Q4 25 | 0.94× | — | ||
| Q3 25 | 0.98× | 0.39× | ||
| Q2 25 | 1.03× | 0.38× | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | 1.25× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | $397.6M |
| Free Cash FlowOCF − Capex | $41.7M | — |
| FCF MarginFCF / Revenue | 13.2% | — |
| Capex IntensityCapex / Revenue | 0.1% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $60.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $397.6M | ||
| Q4 25 | $42.1M | — | ||
| Q3 25 | $30.8M | $138.6M | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $-26.8M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $15.6M | — | ||
| Q2 24 | $8.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | $41.7M | — | ||
| Q3 25 | $30.0M | $126.6M | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $-28.2M | — | ||
| Q4 24 | $34.5M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $7.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | — | ||
| Q3 25 | 10.0% | 23.9% | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | -10.4% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 3.2% | — |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.3% | 2.3% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.47× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFLT
| Confluent Cloud | $169.4M | 54% |
| Post Contract Customer Support | $93.8M | 30% |
| License | $38.4M | 12% |
| Services | $13.2M | 4% |
RAL
Segment breakdown not available.
